Who we are
Reliance Biosciences is a team from the National Taiwan University (NTU) with over 20 years' experience in microfluidics, exosomes, antibody science, surface chemistry, and engineering. The CEO co-founded two companies and headed the NTU tech licensing office responsible for IP, licensing and tech transfer. Reliance collaborates with doctors from the National Taiwan University Hospital, Taipei Veterans General Hospital, Tri-Service General Hospital, Taipei Chang Gung Memorial Hospital, and Taipei Medical University Hospital.
We are passionate about delivering frontier molecular diagnostics for the management of Alzheimer’s Disease. Using a simple blood test, known as liquid biopsy, test results provide personalized, real-time insight contributing to physicians’ decisions in disease management. Our proprietary immunoassay technology enables ultra-high sensitivity protein detection of exosome markers for Alzheimer's disease.
We are passionate about delivering frontier molecular diagnostics for the management of Alzheimer’s Disease. Using a simple blood test, known as liquid biopsy, test results provide personalized, real-time insight contributing to physicians’ decisions in disease management. Our proprietary immunoassay technology enables ultra-high sensitivity protein detection of exosome markers for Alzheimer's disease.
THE TEAM
Andrew Wo
CEO
- PhD, Massachusetts Institute of Technology
- Former Deputy R&D Director and Director of the Industry-University Center, National Taiwan University
- Former Director of Nano Electromechanical System Research Center, National Taiwan University
- Former President of Washington Accord (International Engineering Education Certification)
Alex Tsai
FINANCIAL COMPTROLLER
Prior to joining Reliance, Alex worked with KPMG and E&Y as a Director, providing financial advisory services for large institutions across USA, Australia, Hong Kong, and Taiwan.
- MBACity University of New York
- CPA California, USA
ADVISORS
Jean-Paul Thiery
PhD
- Discover of cellular program epithelial-mesenchymal transition (EMT)
experience
- Head, Dept. of Biochemistry, Yong Loo Lin School of Medicine, NUS
- Research director, IMCB A*STAR, Singapore
- Founding head, Cell Biology Department, Institut Curie, France
